Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Riely, GJ; Wood, DE; Ettinger, DS; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; DeCamp, M; Desai, AP ...
Published in: J Natl Compr Canc Netw
May 2024
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2024
Volume
22
Issue
4
Start / End Page
249 / 274
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Molecular Targeted Therapy
- Lung Neoplasms
- Humans
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Riely, G. J., Wood, D. E., Ettinger, D. S., Aisner, D. L., Akerley, W., Bauman, J. R., … Hang, L. (2024). Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(4), 249–274. https://doi.org/10.6004/jnccn.2204.0023
Riely, Gregory J., Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, et al. “Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 22, no. 4 (May 2024): 249–74. https://doi.org/10.6004/jnccn.2204.0023.
Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, et al. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 May;22(4):249–74.
Riely, Gregory J., et al. “Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 22, no. 4, May 2024, pp. 249–74. Pubmed, doi:10.6004/jnccn.2204.0023.
Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Desai AP, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hang L. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 May;22(4):249–274.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2024
Volume
22
Issue
4
Start / End Page
249 / 274
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasm Staging
- Molecular Targeted Therapy
- Lung Neoplasms
- Humans
- Carcinoma, Non-Small-Cell Lung
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis